Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GLYC

GlycoMimetics (GLYC)

GlycoMimetics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GLYC
DateTimeSourceHeadlineSymbolCompany
03/04/202522:30Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GLYCGlycoMimetics Inc
03/04/202522:30Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GLYCGlycoMimetics Inc
01/03/202509:05Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GLYCGlycoMimetics Inc
27/02/202522:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GLYCGlycoMimetics Inc
26/02/202509:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GLYCGlycoMimetics Inc
26/02/202509:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLYCGlycoMimetics Inc
19/02/202509:13Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:GLYCGlycoMimetics Inc
15/02/202510:38Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GLYCGlycoMimetics Inc
15/02/202508:35Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GLYCGlycoMimetics Inc
15/02/202508:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLYCGlycoMimetics Inc
14/02/202508:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GLYCGlycoMimetics Inc
01/02/202509:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLYCGlycoMimetics Inc
14/01/202501:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GLYCGlycoMimetics Inc
14/01/202501:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLYCGlycoMimetics Inc
27/12/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLYCGlycoMimetics Inc
28/11/202406:22Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:GLYCGlycoMimetics Inc
13/11/202400:00PR Newswire (US)Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024NASDAQ:GLYCGlycoMimetics Inc
08/11/202408:47Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GLYCGlycoMimetics Inc
08/11/202408:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLYCGlycoMimetics Inc
07/11/202409:41Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:GLYCGlycoMimetics Inc
06/11/202423:00Business WireGlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual MeetingNASDAQ:GLYCGlycoMimetics Inc
05/11/202408:26Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:GLYCGlycoMimetics Inc
05/11/202406:01Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GLYCGlycoMimetics Inc
30/10/202401:00AllPennyStocks.comShares of Biotech Company Up Over 100% Premarket Following Merger & Funding AnnouncementNASDAQ:GLYCGlycoMimetics Inc
30/10/202401:00AllPennyStocks.comBiotech Up Over +100% Premarket Following Merger And Funding AnnouncementNASDAQ:GLYCGlycoMimetics Inc
29/10/202423:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GLYCGlycoMimetics Inc
29/10/202423:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLYCGlycoMimetics Inc
29/10/202422:00Business WireGlycoMimetics Enters Into Acquisition Agreement With Crescent BiopharmaNASDAQ:GLYCGlycoMimetics Inc
29/10/202421:30Business WireGlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary EndpointNASDAQ:GLYCGlycoMimetics Inc
16/08/202407:01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GLYCGlycoMimetics Inc
 Showing the most relevant articles for your search:NASDAQ:GLYC